Psychiatrist Dr. Mark Johnston as CMO and senior pharmaceutical commercialization expert Greg Rutherford as CCO accelerates APEX’s ability to bring new drugs to market. VANCOUVER, BC, Aug. 10, 2023 /CNW/ – Apex Labs Ltd. (APEX or the Company), a pharmaceutical company transforming the standard of mental health care with clinically proven psilocybin treatments, announces the addition of two new…


Previous articleOptimi Health Announces CAD $3,000,000 Senior Debt Financing
Next articlePT431 – The Concept of Integration and the Need for Evolving Protocols of Psychedelic Therapy